The menopause transition: the next neuroendocrine frontier

References

• Soules MR, Sherman S, Parrott E et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil. Steril.76, 874–878 (2001).
   PubMedGoogle Scholar
• Maffucci JA, Gore AC. Age-related changes in hormones and their receptors in animal models of female reproductive senescence. In: Handbook of Models for Human Aging. Conn PM (Ed.), Academic Press/Elsevier, New York, NY, USA (2006).
   Google Scholar
• Yin W, Gore AC. Neuroendocrine control of reproductive aging: roles of GnRH neurons. Reproduction131, 403–414 (2006).
   PubMed Web of Science ®Google Scholar
• Santoro N. The menopausal transition. Am. J. Med.118, 8S–13S (2005).
   PubMed Web of Science ®Google Scholar
• Hall JE, Gill S. Neuroendocrine aspects of aging in women. Endocrinol. Metab. Clin. North Am.30, 631–646 (2001).
   PubMed Web of Science ®Google Scholar
• Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J. Clin. Endocrinol. Metab.85, 2832–2838, (2000).
   PubMed Web of Science ®Google Scholar
• Davison SL, Donath S, Montalto JG, DavisSR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab.90, 3847–3853, (2005).
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Meyer PM, Kravitz HM et al. Psychologic distress and natural menopause: a multiethnic community study. Am. J. Public Health91, 1435–1442 (2001).
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Liu L et al. Hormones and menopausalstatus as predictors of depression in women in transition to menopause. Arch. Gen. Psychiatry61, 62–70 (2004).
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch. Gen. Psychiatry63, 375–382 (2006).
   PubMed Web of Science ®Google Scholar
• Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition. The Harvard study of moods and cycles. Arch. Gen. Psychiatry63, 385–390 (2006).
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Matthews KA, Schott LL etal. Depressive symptoms during the menopausal transition: the study of women’s health across the nation (SWAN). J.Affect. Disord. PMID: 17331589 (2007) (Epub ahead of print).
   PubMedGoogle Scholar
• Schmidt PJ, Haq NA, Rubinow DR. A longitudinal evaluation of the relationship between reproductivestatus and mood in perimenopausal women. Am. J. Psychiatry161, 2238–2244 (2004).
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Murphy JH, Haq NA, Rubinow DR, Danaceau M. Stressful life events, personal losses, and perimenopause-related depression. Arch. Womens Ment. Health7, 19–26, (2004).
   PubMedGoogle Scholar
• Woods NF, Mitchell ES, Adams C. Memory functioning among midlife women: observations from the Seattle midlife women’s health study. Menopause7, 257–265 (2000).
   PubMed Web of Science ®Google Scholar
• Maki PM, Zonderman AB, Resnick SM. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am. J. Psychiatry158, 227–233 (2001).
   PubMed Web of Science ®Google Scholar
• Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology60, 1369–1371 (2003).
   PubMed Web of Science ®Google Scholar
• Sherwin BB. Estrogen and cognitive functioning in women. Endocr. Rev.24, 133–151 (2003).
   PubMed Web of Science ®Google Scholar
• Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA279, 688–695 (1998).
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA285, 1489–1499 (2001).
   PubMed Web of Science ®Google Scholar
• Hogervorst E, Yaffe K, Richards M, Huppert F. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev.CD003122 (2002).
   Google Scholar
• Pradhan AD, Manson JE, Rossouw JE et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the women’s health initiative observational study. JAMA288, 980–987 (2002).
   PubMed Web of Science ®Google Scholar
• Harris RP, Helfand M, Woolf SH et al. Current methods of the U.S. Preventive Services Task Force: a review of the process. Am. J. Prev. Med.20, 21–35 (2001).
   PubMed Web of Science ®Google Scholar
• Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J. Neurosci.26, 10332–10348 (2006).
   PubMed Web of Science ®Google Scholar
• Zandi PP, Carlson MC, Plassman BL et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA288, 2123–2129 (2002).
   PubMed Web of Science ®Google Scholar
• Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age. J. Neurol. Neurosurg. Psychiatry76, 103–105 (2005).
   PubMed Web of Science ®Google Scholar
• Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA288, 2170–2172 (2002).
   PubMed Web of Science ®Google Scholar
• Manson JE, Bassuk SS, Harman M et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause13, 139–147 (2006).
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA297, 1465–1477 (2007).
   PubMed Web of Science ®Google Scholar